Akumin Inc. (AKU) |
|
1.01 -0.03 (-2.88%)
|
11-28 16:00 |
|
Open: |
1.03 |
Pre. Close: |
1.04 |
|
High:
|
1.03 |
Low:
|
0.98 |
|
Volume:
|
25,951 |
Market Cap:
|
91(M) |
|
|
|
Technical analysis |
as of: 2022-11-28 4:37:48 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 1.81 One year: 2.24 |
| Support: |
Support1: 0.97 Support2: 0.8 |
| Resistance: |
Resistance1: 1.55 Resistance2: 1.91 |
| Pivot: |
1.22  |
| Moving Average: |
MA(5): 1.01 MA(20): 1.32
MA(100): 1.33  MA(250): 1.21 |
| MACD: |
MACD(12,26): -0.2 Signal(9): -0.2 |
| Stochastic oscillator: |
%K(14,3): 7.4 %D(3): 5.9 |
| RSI: |
RSI(14): 29.8 |
| 52-week: |
High: 2.3 Low: 0.46 |
| Average Vol(K): |
3-Month: 116 (K) 10-Days: 25 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ AKU ] has closed above bottom band by 25.7%. Bollinger Bands are 37.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.03 - 1.04 |
1.04 - 1.04 |
|
Low:
|
0.97 - 0.97 |
0.97 - 0.98 |
|
Close:
|
1 - 1.01 |
1.01 - 1.02 |
|
Company Description |
|
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. |
Headline News |
Mon, 28 Nov 2022
No candidate for national award, nominees fail exam - Punch Newspapers
Sun, 27 Nov 2022
A'o Aku; A'o Mai: What I Learn, I Teach | The Molokai Dispatch - Molokai Dispatch
Thu, 24 Nov 2022
Aku Benya -The Ahanta Woman Who Burned Enemy Villages To Avenge Her Relatives - Modern Ghana
Sat, 19 Nov 2022
A Monumental Partnership: AKU and SFU enter into an MOU - The Aga Khan University
Wed, 16 Nov 2022
AKU-IED Hosts Global Meet on Learnings from the Pandemic - The Aga Khan University
Tue, 15 Nov 2022
Blackfish: Aku Koskenvuo's rising stock for the World Juniors, Arturs Silovs is the AHL starter, and Linus Karlsson continue to trend upwards in Abbotsford - Canucks Army
|
Financial Analysis |
| Price to Book Value: |
Underperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Outperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Underperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
90 (M) |
| Shares Float |
46 (M) |
|
% Held by Insiders
|
35.9 (%) |
|
% Held by Institutions
|
29.6 (%) |
|
Shares Short
|
264 (K) |
|
Shares Short P.Month
|
338 (K) |
Stock Financials |
|
EPS
|
-0.88 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
-0.08 |
|
Profit Margin (%)
|
-19.8 |
|
Operating Margin (%)
|
4.4 |
|
Return on Assets (ttm)
|
1.1 |
|
Return on Equity (ttm)
|
-46 |
|
Qtrly Rev. Growth
|
72.5 |
|
Gross Profit (p.s.)
|
1.04 |
|
Sales Per Share
|
8.3 |
|
EBITDA (p.s.)
|
1.48 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
60 (M) |
|
Levered Free Cash Flow
|
23 (M) |
Stock Valuations |
|
PE Ratio
|
-1.16 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
-12.63 |
|
Price to Sales
|
0.12 |
|
Price to Cash Flow
|
1.5 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
